Interaction of methotrexate poly(L-lysine) with transformed hepatic cells in culture.
D000818:Animals; D001692:Biological Transport / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D007700:Kinetics; D002955:Leucovorin / Q000494:pharmacology; D007976:Leupeptins / Q000494:pharmacology; D008114:Liver Neoplasms, Experimental / Q000503:physiopathology*; D008727:Methotrexate / Q000378:metabolism / Q000494:pharmacology* / Q000031:analogs & derivatives; D010455:Peptides / Q000494:pharmacology*; D011107:Polylysine / Q000378:metabolism / Q000494:pharmacology* / Q000031:analogs & derivatives; D051381:Rats
D007976:Leupeptins; D010455:Peptides; D011107:Polylysine; C030305:methotrexate-polylysine; C032854:leupeptin; D002955:Leucovorin; D008727:Methotrexate